Amlodipine Cost in Nevada 2026: Cash Price, Medicaid, Insurance, and Discount Options

What Does Amlodipine Actually Cost at Nevada Pharmacies in 2026?

Generic amlodipine is one of the least expensive prescription drugs available in the United States, and Nevada is no exception. Cash-pay prices at major Nevada retail pharmacies average roughly $8 per month for a 30-tablet supply of the 5 mg or 10 mg tablet in 2026. Pfizer's branded Norvasc carries a manufacturer list price near $80 per month, but fewer than 5% of patients pay that figure given generic availability since 2007.

Prices vary by chain, independent pharmacy, and whether you apply a discount card at checkout. The table below captures representative 2026 Nevada cash prices for a 30-count supply of generic amlodipine 5 mg:

| Pharmacy | Approx. Cash Price (30-count, 5 mg) | |---|---| | Walmart (Reno, Las Vegas) | $4, $6 | | Costco (Henderson, Sparks) | $5, $7 | | Walgreens (statewide) | $10, $15 | | CVS (statewide) | $11, $16 | | Smith's / Kroger | $6, $8 | | Independent / compounding | $0, $12 (see 503A section) |

Amlodipine is a long-acting dihydropyridine calcium channel blocker approved by the FDA in 1992 for hypertension and chronic stable or vasospastic angina [1]. Its half-life of 30 to 50 hours supports once-daily dosing, which aids adherence. The FDA prescribing information confirms approved doses of 2.5 mg, 5 mg, and 10 mg [1].

The ASCOT-BPLA trial (N=19,257, Lancet 2005) compared amlodipine-based therapy with atenolol-based therapy in hypertensive patients at cardiovascular risk. Amlodipine reduced the primary endpoint (non-fatal myocardial infarction plus fatal coronary heart disease) by 10% relative to atenolol, with the trial stopped early due to significant mortality differences [2]. Those outcome data help explain why amlodipine appears on virtually every formulary in Nevada.

GoodRx and similar discount platforms routinely show prices of $4, $9 at Nevada locations for a 30-day supply. Applying a GoodRx coupon at Walmart in Las Vegas typically returns a price of $4, $5 [3]. The GoodRx methodology page confirms that coupon platforms negotiate rates below the pharmacy's usual-and-customary cash price through pharmacy benefit intermediaries [3].

Does Nevada Medicaid Cover Amlodipine?

Nevada Medicaid does not currently list standalone amlodipine (besylate, generic or branded) as a covered benefit on the 2025 to 2026 Nevada Check Up and Medicaid preferred drug list. This is an unusual omission given the drug's low cost and strong evidence base.

Nevada Medicaid is administered through the Division of Health Care Financing and Policy (DHCFP). The Nevada DHCFP Preferred Drug List undergoes quarterly review, and prescribers may submit a prior authorization (PA) request if a clinical case can be made that the patient requires amlodipine over a currently listed alternative [4]. The American Heart Association 2023 hypertension guidelines note that calcium channel blockers, thiazides, ACE inhibitors, and ARBs all carry Class I, Level A evidence for first-line use in hypertension [5]. That guideline language can support a PA narrative.

Nevada Medicaid does cover several alternative calcium channel blockers and diuretics at no cost to the patient. If amlodipine is not accessible via PA, a prescriber may substitute felodipine or nifedipine extended-release, both of which share the dihydropyridine mechanism. A direct conversion does not exist in milligram terms; the JNC 8 guideline panel recommends titrating to blood pressure response rather than dose-matching across agents [6].

Patients who are dual-eligible (Medicare plus Medicaid) may access amlodipine through their Medicare Part D plan's formulary at little or no cost-sharing, since most Part D plans place generic amlodipine on Tier 1 at a $0, $5 copay.

How Private Insurance Covers Amlodipine in Nevada

Most Nevada commercial plans place generic amlodipine on Tier 1 (preferred generic), which typically means a $0, $10 copay per 30-day fill. Branded Norvasc sits on Tier 3 or Tier 4 on most formularies.

Nevada's largest commercial insurers by enrollment include UnitedHealthcare, Anthem Blue Cross Blue Shield of Nevada, Aetna, and Nevada Health CO-OP (which operates on the state exchange). All four place generic amlodipine on their lowest formulary tier for the 2025 to 2026 plan year based on publicly available formulary documents.

The Academy of Managed Care Pharmacy (AMCP) formulary guidelines describe generic placement criteria: drugs with three or more AB-rated generic competitors and a wholesale acquisition cost below $30 for a 30-day supply are strong candidates for Tier 1 placement [7]. Generic amlodipine meets both criteria decisively.

Patients with high-deductible health plans (HDHPs) may face the full cash price until their deductible is met. In that case, using a GoodRx or Blink Health coupon instead of running the claim through insurance often produces a lower out-of-pocket cost, since coupon prices ($4, $9) typically fall below even negotiated insurance rates during deductible periods.

Medicare Part D beneficiaries in Nevada should check the Medicare Plan Finder annually. In the 2025 to 2026 benefit year, the Inflation Reduction Act caps total out-of-pocket drug spending at $2,000 annually for Part D enrollees, and Tier 1 generics like amlodipine typically carry a $0, $5 copay after the deductible [8].

Pfizer Savings Card and Generic Manufacturer Programs in Nevada

Pfizer offers a savings card for branded Norvasc through its PfizerRxPathways program. Eligible commercially insured patients may pay as little as $0 per month; cash-pay patients without insurance may qualify for reduced pricing through the Pfizer Patient Assistance Program. Nevada residents can enroll at PfizerRxPathways.com or call 1-866-706-2400.

Given that generic amlodipine already costs $4, $9 cash-pay at Nevada pharmacies, the Pfizer savings card primarily benefits patients whose prescriber has written "Dispense as Written" for brand-name Norvasc or patients who experience tolerability differences with specific generic formulations. The FDA's Orange Book confirms multiple AB-rated generic equivalents are approved and therapeutically substitutable [1].

Generic manufacturers including Mylan (now Viatris), Teva, Zydus, and Amneal do not typically operate individual patient savings cards for amlodipine, because the cash price is already below $10. However, GoodRx Gold membership (approximately $9.99/month for individuals) can reduce amlodipine to under $5 at participating Nevada pharmacies.

The National Council for Prescription Drug Programs (NCPDP) has documented that third-party coupon programs reduce patient cost-sharing but may affect pharmacy reimbursement and insurer rebate calculations [9]. Patients should be aware that using a coupon in lieu of insurance means the fill does not count toward their deductible.

Is Compounded Amlodipine Legal in Nevada?

Compounded amlodipine is legal in Nevada when prepared by a state-licensed 503A pharmacy operating under a valid patient-specific prescription. The cost is effectively $0 in specific clinical scenarios where a compounding pharmacy bundles amlodipine into a combination formulation or when a patient receives it as part of a managed hypertension program.

Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies. They must operate under state pharmacy board licensure, compound only for individual patient prescriptions, and use FDA-approved bulk drug substances or those on the 503A bulks list [10]. The Nevada State Board of Pharmacy (NSBOP) licenses and inspects 503A compounders in the state.

Amlodipine besylate is available as a USP-grade bulk substance and is not on the FDA's list of drugs withdrawn from the market for safety or efficacy reasons, making it eligible for 503A compounding [10]. Common scenarios where compounding adds clinical value include patients requiring a liquid formulation for dysphagia, pediatric dose adjustments (<2.5 mg), or fixed-dose combination preparations not available commercially.

Section 503B outsourcing facilities (hospital-supply compounders) are a separate category. They do not require patient-specific prescriptions but must register with the FDA and follow current good manufacturing practices (cGMP) [10]. Nevada has several 503B-registered facilities; their amlodipine output is directed at institutional purchasers rather than retail patients.

Prescribers considering compounded amlodipine should confirm the compounding pharmacy holds an active Nevada license, verify the formulation is medically necessary over the commercially available tablet, and document the clinical rationale. The FDA's 2023 guidance on 503A compounding clarifies that routine compounding of a commercially available drug to obtain a lower price, absent a clinical reason, does not meet the "not commercially available" standard [10].

Can Nevada Patients Get an Amlodipine Prescription via Telehealth?

Yes. Telehealth prescribing of amlodipine is fully legal in Nevada for established patient relationships and, in many cases, for new patients under Nevada's expanded telehealth statute (NRS 629.515). Nevada was an early adopter of telehealth parity legislation, requiring insurers to reimburse telehealth visits at the same rate as in-person visits since 2019.

The Ryan Haight Online Pharmacy Consumer Protection Act imposes prescribing restrictions for controlled substances but does not affect amlodipine, which is not a controlled substance [11]. A Nevada-licensed prescriber can therefore issue an amlodipine prescription via audio-visual telehealth, telephone (with documentation), or asynchronous platforms.

Telehealth platforms operating in Nevada, including HealthRX, can evaluate hypertension, review home blood pressure logs, and prescribe amlodipine within a single visit. Home blood pressure monitoring with validated upper-arm cuffs (validated per the VALIDATE-BP registry) is sufficient to support prescribing decisions in the telehealth setting [12]. The ACC/AHA 2017 hypertension guideline endorses out-of-office blood pressure measurement as a core component of hypertension diagnosis and management [13].

Patients using telehealth to obtain amlodipine in Nevada should expect an intake questionnaire covering blood pressure history, cardiac history, current medications, and any prior calcium channel blocker use. Refill visits are typically shorter (10 to 15 minutes) than initial evaluations (20 to 30 minutes).

What Is the Cheapest Way to Get Amlodipine in Nevada?

The least expensive route depends on insurance status and whether a clinical rationale supports compounding.

Uninsured patients should request generic amlodipine at Walmart ($4, $6) with a GoodRx coupon applied. This approach requires no membership and no prior authorization. A 90-day supply at Walmart with a GoodRx coupon typically costs $10, $15 total, roughly $3.50, $5 per month.

Medicaid patients face the coverage gap described above. Seeking a PA for amlodipine or asking the prescriber to substitute a covered calcium channel blocker remains the primary option. If a PA is approved, cost to the patient is $0.

Commercially insured patients should verify their Tier 1 copay (usually $0, $10) before applying a coupon, since running a coupon bypasses the deductible accumulator.

Medicare Part D patients should confirm their plan's Tier 1 copay and use Medicare Plan Finder during open enrollment to select the plan with the lowest total cost for their full drug regimen [8].

The CDC's 2023 High Blood Pressure Fact Sheet notes that approximately 47% of U.S. adults have hypertension, yet medication adherence remains below 50% at 12 months in many populations [14]. Cost is one of the top barriers cited. Choosing the lowest-cost dispensing channel for amlodipine directly addresses that barrier.

Amlodipine Dosing and Clinical Context Relevant to Cost Decisions

Dose affects cost modestly. The standard starting dose is 5 mg once daily for hypertension, titrated to 10 mg if blood pressure remains above goal after 7 to 14 days [1]. The 2.5 mg tablet is used in elderly patients, those with hepatic impairment, or pediatric patients. All three strengths (2.5 mg, 5 mg, 10 mg) are priced comparably at Nevada pharmacies, so titration does not materially change monthly cost.

Amlodipine is frequently prescribed as part of a fixed-dose combination. Exforge (amlodipine/valsartan) and Caduet (amlodipine/atorvastatin) are two common branded combinations. Both have generic equivalents available in Nevada, though combination tablets cost more (typically $15, $40/month cash) than amlodipine alone. Patients on multiple cardiovascular agents should compare the cost of individual generics versus the combination tablet at their specific pharmacy.

The ACCOMPLISH trial (N=11,506) compared amlodipine plus benazepril versus hydrochlorothiazide plus benazepril and found the amlodipine combination reduced the primary composite cardiovascular outcome by 19.6% relative to the diuretic combination (hazard ratio 0.80 to 95% CI 0.72, 0.90, P<0.001) [15]. That evidence supports continuing amlodipine over substituting a diuretic when cost alone is not the driving concern.

The AHA/ACC 2022 Guideline on Hypertension Management states: "Calcium channel blockers, particularly dihydropyridines, are recommended as first-line antihypertensive agents given their proven reduction in cardiovascular morbidity and mortality across diverse patient populations" [13]. This clinical weight is one reason generic amlodipine maintains universal formulary presence despite its minimal cost.

Nevada-Specific Cost Navigation Framework

The following decision framework applies to Nevada patients seeking the lowest amlodipine cost in 2026:

Step 1. Confirm prescription is written for generic amlodipine besylate (not "Dispense as Written" for Norvasc). A DAW code 1 on the prescription forces branded dispensing and can increase cost by $60, $70/month.

Step 2. Check your insurance formulary tier before filling. Most Nevada commercial plans charge $0, $10 for Tier 1 generics. Log into your insurer's portal or call the member services number on your card.

Step 3. Compare the insurance copay to the GoodRx cash price at your preferred pharmacy. If your deductible is unmet, the GoodRx price ($4, $9 at most Nevada locations) may be lower than what your plan charges pre-deductible.

Step 4. For 90-day supplies, use mail-order or a warehouse pharmacy (Costco, Walmart). A 90-day supply typically costs $10, $18 at Walmart or Costco in Nevada, reducing per-dose cost.

Step 5. If you are on Nevada Medicaid, ask your prescriber to submit a PA or discuss switching to a covered calcium channel blocker. Document blood pressure response to justify the specific agent.

Step 6. If a liquid or non-standard-dose formulation is clinically required, ask your prescriber about 503A compounding. Confirm the pharmacy holds an active Nevada Board of Pharmacy license before dispensing.

Patients who complete all six steps typically pay $0, $10 per month for amlodipine in Nevada. The national average retail price for a 30-day supply of generic amlodipine was $10.89 in 2023 per the AHRQ Medical Expenditure Panel Survey, meaning Nevada's competitive pharmacy market keeps local prices below the national average [16].

Side Effects That May Affect Adherence and Cost

Peripheral edema occurs in 10.8% of patients taking amlodipine 10 mg daily per the FDA prescribing label, compared with 1.8% on placebo [1]. Some patients and prescribers manage edema by reducing the dose to 5 mg or switching to a different calcium channel blocker, which changes cost and formulary dynamics.

Flushing occurs in roughly 2.6% of patients and headache in 7.3% at the 10 mg dose [1]. Neither side effect typically requires discontinuation, but both are commonly cited when patients seek a prescriber visit, which adds an indirect cost to therapy. The Agency for Healthcare Research and Quality has documented that adverse effects are a leading cause of antihypertensive non-adherence, with direct cost implications when patients skip refills or switch agents [17].

Patients who develop significant edema on amlodipine may tolerate felodipine or isradipine better, though both are slightly more expensive generics ($12, $20/month cash in Nevada). Discussing tolerability alongside cost at the prescribing visit avoids a second visit and a formulary substitution workup.